Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL28B polymorphism study in HBeAg-negative chronic hepatitis B treated within Peg.Be.Liver
2012-002777-56Phase 3Completed
- Sponsor
- Roche
- Start
- Aug 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of peginterferon alfa-2a and lamivudine in Chronic Hepatitis B (CHB) and Chronic hepatitis B (CHB), sponsored by Roche. Started Aug 2012; status: completed.
02
Drugs
peginterferon alfa-2alamivudine
03
Conditions
Chronic Hepatitis B (CHB)Chronic hepatitis B (CHB)
Beyond the preview
Go deeper on 2012-002777-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002777-56.